21-fluoro-16-ethyl-19-norprogesterone has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Goeij, CC; Go, KG; Luurtsema, G; Nieweg, OE; Sluyser, M; Studeny, M; Vaalburg, W; Van der Ploeg, E; Verhagen, A; Visser, GM | 1 |
| de Goeij, CJ; de Groot, TJ; Elsinga, PH; Paans, AM; Sluyser, M; Vaalburg, W; Verhagen, A | 1 |
2 other study(ies) available for 21-fluoro-16-ethyl-19-norprogesterone and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Metabolism of a [18F]fluorine labeled progestin (21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone) in humans: a clue for future investigations.
Topics: Animals; Biotransformation; Brain Neoplasms; Breast Neoplasms; Fluorine Radioisotopes; Gas Chromatography-Mass Spectrometry; Humans; In Vitro Techniques; Mammary Neoplasms, Experimental; Meningioma; Mice; Norprogesterones; Receptors, Estrogen; Receptors, Progesterone; Tomography, Emission-Computed | 1994 |
A fluorine-18 labeled progestin as an imaging agent for progestin receptor positive tumors with positron emission tomography.
Topics: Animals; Female; Mammary Neoplasms, Experimental; Mice; Neoplasms, Hormone-Dependent; Norprogesterones; Rats; Receptors, Estrogen; Receptors, Progesterone; Tomography, Emission-Computed; Uterus | 1991 |